The SureSelect 92-gene custom panel detected the APC insertion in bulk tumor DNA (AF:9.8%) and also in circulating cfDNAs analyzed at two different time points (ccfDNA at diagnosis, AF: 22.6% and ccfDNA at the progression of the disease, AF:29.9%). The gene discussed is APC; the disease is neoplasm.